5,174
Views
8
CrossRef citations to date
0
Altmetric
Report

Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response

, , , , , , , , , , , , , , , , , ORCID Icon, , , , , , , , & show all
Article: 1862452 | Received 05 Oct 2020, Accepted 07 Dec 2020, Published online: 31 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Danielle M. Dicara, Sunil Bhakta, Mary Ann Go, James Ziai, Ron Firestein, Bill Forrest, Chen Gu, Steven R. Leong, Genee Lee, Shang-Fan Yu, Andrew G. Polson & Nicholas J. Agard. (2022) Development of T-cell engagers selective for cells co-expressing two antigens. mAbs 14:1.
Read now

Articles from other publishers (7)

Dipankar Pramanik. (2023) Development of Antibody-Drug Conjugates: Future Perspective Towards Solid Tumor Treatment. Anti-Cancer Agents in Medicinal Chemistry 23:6, pages 642-657.
Crossref
George Jour, Irineu Illa-Bochaca, Milad Ibrahim, Douglas Donnelly, Kelsey Zhu, Eleazar Vega-Saenz de Miera, Varshini Vasudevaraja, Valeria Mezzano, Sitharam Ramswami, Yu-Hsin Yeh, Carolyn Winskill, Rebecca A. Betensky, Janice Mehnert & Iman Osman. (2023) Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment. Journal of Investigative Dermatology 143:3, pages 444-455.e8.
Crossref
Irena Voinsky, Yazeed Zoabi, Noam Shomron, Moria Harel, Hanoch Cassuto, Joseph Tam, Shannon Rose, Adrienne C. Scheck, Mohammad A. Karim, Richard E. Frye, Adi Aran & David Gurwitz. (2022) Blood RNA Sequencing Indicates Upregulated BATF2 and LY6E and Downregulated ISG15 and MT2A Expression in Children with Autism Spectrum Disorder. International Journal of Molecular Sciences 23:17, pages 9843.
Crossref
Stefan G. Koenig, Rémy Angelaud, Christopher M. Crittenden, Kenji Kurita, David J. Russell, Jean-Francois Marcoux, Thomas Matt & Francis Gosselin. (2022) Development of Dual Practical Manufacturing Routes to Cognate Pyrrolobenzodiazepine-Based Linker-Drugs. Organic Process Research & Development 26:8, pages 2155-2175.
Crossref
Yujie Zhang, Zhichao Xing, Li Mi, Zhihui Li, Jingqiang Zhu, Tao Wei & Wenshuang Wu. (2022) Novel Agents For Relapsed and Refractory Classical Hodgkin Lymphoma: A Review. Frontiers in Oncology 12.
Crossref
Qian Zhang, Ying Jia, Pan Pan, Xiuping Zhang, Yanfei Jia, Ping Zhu, Xiaowei Chen, Yang Jiao, Guiyu Kang, Lulu Zhang & Xiaoli Ma. (2022) α5-nAChR associated with Ly6E modulates cell migration via TGF-β1/Smad signaling in non-small cell lung cancer. Carcinogenesis 43:4, pages 393-404.
Crossref
Ting Li, Weidong Liu, Chun Wang, Man Wang, Wenjia Hui, Jiajie Lu & Feng Gao. (2022) Multidimension Analysis of the Prognostic Value, Immune Regulatory Function, and ceRNA Network of LY6E in Individuals with Colorectal Cancer. Journal of Immunology Research 2022, pages 1-19.
Crossref